Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Korkola

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Current Opinion in Genetics & Development|January 12, 2010
Breast cancer genomes--form and functionJames Korkola, Joe W Gray
Microarrays (Basel, Switzerland)|September 9, 2016
Expanding the Diversity of Imaging-Based RNAi Screen Applications Using Cell Spot MicroarraysJuha K Rantala, Sunjong Kwon, James Korkola, et al.
Bioinformatics (Oxford, England)|August 28, 2014
Causal network inference using biochemical kineticsChris J Oates, Frank Dondelinger, Nora Bayani, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
S-Nitrosylated COX-2 is a TME-regulated breast cancer biomarker of mesenchymal phenotypesReuben J Hoffmann, AeSoon Bensen, Mark Dane, et al.
Experimental Cell Research|January 9, 2026
S-Nitrosylated COX-2 is a microenvironment-regulated breast cancer cell biomarker of mesenchymal phenotypesReuben J Hoffmann, AeSoon Bensen, Mark Dane, et al.
Plos One|April 23, 2015
Disentangling multidimensional spatio-temporal data into their common and aberrant responsesYoung Hwan Chang, James Korkola, Dhara N Amin, et al.
Plos One|March 26, 2019
Targeting mitochondria in cancer therapy could provide a basis for the selective anti-cancer activityDmitri Rozanov, Anton Cheltsov, Aaron Nilsen, et al.
European Journal of Cell Biology|October 18, 2020
Crosstalk between invadopodia and the extracellular matrixShinji Iizuka, Ronald P Leon, Kyle P Gribbin, et al.
Science Advances|September 15, 2018
Cell fusion potentiates tumor heterogeneity and reveals circulating hybrid cells that correlate with stage and survivalCharles E Gast, Alain D Silk, Luai Zarour, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Current Opinion in Genetics & Development|January 12, 2010
Breast cancer genomes--form and functionJames Korkola, Joe W Gray
Microarrays (Basel, Switzerland)|September 9, 2016
Expanding the Diversity of Imaging-Based RNAi Screen Applications Using Cell Spot MicroarraysJuha K Rantala, Sunjong Kwon, James Korkola, et al.
Bioinformatics (Oxford, England)|August 28, 2014
Causal network inference using biochemical kineticsChris J Oates, Frank Dondelinger, Nora Bayani, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
S-Nitrosylated COX-2 is a TME-regulated breast cancer biomarker of mesenchymal phenotypesReuben J Hoffmann, AeSoon Bensen, Mark Dane, et al.
Experimental Cell Research|January 9, 2026
S-Nitrosylated COX-2 is a microenvironment-regulated breast cancer cell biomarker of mesenchymal phenotypesReuben J Hoffmann, AeSoon Bensen, Mark Dane, et al.
Plos One|April 23, 2015
Disentangling multidimensional spatio-temporal data into their common and aberrant responsesYoung Hwan Chang, James Korkola, Dhara N Amin, et al.
Plos One|March 26, 2019
Targeting mitochondria in cancer therapy could provide a basis for the selective anti-cancer activityDmitri Rozanov, Anton Cheltsov, Aaron Nilsen, et al.
European Journal of Cell Biology|October 18, 2020
Crosstalk between invadopodia and the extracellular matrixShinji Iizuka, Ronald P Leon, Kyle P Gribbin, et al.
Science Advances|September 15, 2018
Cell fusion potentiates tumor heterogeneity and reveals circulating hybrid cells that correlate with stage and survivalCharles E Gast, Alain D Silk, Luai Zarour, et al.
Pageof 1